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Abstract
Background Magnetic resonance imaging and com-
puted tomography in patients with ventricular tachy-
cardia (VT) after myocardial infarction (MI) helps to
delineate scar from healthy tissue. Image-guided VT
ablation has not yet been studied on a large scale.
Objective The aim of the meta-analysis was to com-
pare the long-term outcome of image-guided VT ab-
lation with a conventional approach for VT after MI.
Methods Eight electronic bibliographic databases
were searched to identify all relevant studies from
2012 until 2018. The search for scientific literature
was performed for studies that described the out-
come of VT ablation in patients with an ischaemic
substrate. The outcome of image-guided ablation
was compared with the outcome of conventional
ablations.
Results Of the 2990 citations reviewed for eligibility,
38 articles—enrolling a total of 7748 patients—were
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included into the meta-analysis. Five articles included
patients with image-guided ablation. VT-free survival
was 82% [74–90] in the image-guided VT ablation ver-
sus 59% [54–64] in the conventional ablation group
(p< 0.001) during a mean follow-up of 35 months.
Overall survival was 94% [90–98] in the image-guided
versus 82% [76–88] in the conventional VT ablation
group (p< 0.001).
Conclusions Image-guided VT ablation in ischaemic
VT was associated with a significant benefit in VT-free
and overall survival as compared with conventional
VT ablation. Visualising myocardial scar facilitates
substrate-guided ablation procedures, pre-procedu-
rally and by integrating imaging during the procedure,
and may consequently improve long-term outcome.
Keywords Magnetic resonance imaging · Computed
tomography · Ventricular tachycardia · Catheter
ablation · Meta-analysis
Introduction
Magnetic resonance imaging (MRI) and computed to-
mography advancing ventricular tachycardia (VT) ab-
lation have an important role in diagnosing struc-
What’s new
 The use of imaging guidance in ventricular
tachycardia (VT) ablation for patients with is-
chaemic heart disease is associated with higher
VT-free survival.
 This is the first study that demonstrates a true
large-scale benefit of visualising myocardial scar
and integrating imaging in a VT ablation proce-
dure.
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tural heart disease. In patients with VT after my-
ocardial infarction (MI) these modalities of imaging
help to identify, delineate and characterise the scar.
Electroanatomical mapping can be used to define the
scar and border zone. However, scar is 3dimensional
and a voltage map is limited in spatial resolution [1].
Moreover, arrhythmogenic substrate may be found in
heterogeneous tissue with normal voltages [2]. Chan-
nels that correlate with critical VT isthmuses can be
identified by searching the scar for abnormal poten-
tials. This may be time consuming and often incom-
plete. High-resolution MRI has been demonstrated to
be able to delineate areas of surviving myocardial tis-
sue within the scar that correlate with VT channels [3].
MRI preceding VT ablation can accurately predict re-
currences in the presence of scar [4] and is a promising
tool to identify ablation strategy in case of transmural
scar [5].
Currently randomised and large scale trials lack on
the long term outcome of image-guided VT ablation.
The aim of the current meta-analysis is to perform
a large scale analysis, comparing the long term out-
come of image-guided VT ablation to a conventional
VT ablation approach.
Methods
Data sources and search strategy
This review was conducted in accordance with the
PRISMA and MOOSE guidelines (Appendix 1 and 2).
The purpose of our study was to identify all studies
that use imaging modalities to focus on scar that
is performed prior to ablation for ischaemic VT. We
searched Embase.com, Medline via Ovid, Web-of-sci-
ence Core collection, the Cochrane Central registry
of trials, Scopus, CINAHL via EBSCOhost and Google
Scholar from January 2012 until January 2018. The
search strategy was created with the assistance of
a medical librarian (WB). The search strategy com-
bined terms for ventricular tachycardia and catheter
ablation, and terms for myocardial scar due to previ-
ous ischaemic injury. The search results were limited
to English language articles. The detailed search
methodology for all databases is provided in Ap-
pendix 3.
Study selection and data extraction criteria
Studies were included if they: (i) were observational
studies or randomised controlled trials (ii) reported on
long-term follow-up of patients who underwent per-
cutaneous catheter ablation for ischaemic VT, (iii) pro-
vided data on recurrences with a follow-up duration of
>1 year. Articles that focused on patients with struc-
tural heart disease other than ischaemic scar were ex-
cluded. Also, if the studied population was heteroge-
neous and we were not able to extract the outcome
of the patients with ischaemic VT, the study was ex-
cluded. Individual case reports, editorials, review ar-
ticles and conference meeting abstracts were not in-
cluded. We compared image-guided VT ablation with
non-image-guided VT ablation. If imaging was per-
formed preceding VT ablation but did not influence
the ablation procedure, it was seen as non-image-
guided VT ablation.
Two reviewers (AAH, ZK) independently evaluated
the titles and abstracts according to the inclusion and
exclusion criteria. For each potentially eligible study,
two reviewers assessed the full-text. In cases of dis-
agreement, a decision was made by consensus or,
if necessary, a third reviewer (TSZT). was consulted.
A predesigned data extraction form was used to col-
lect relevant information on baseline characteristics,
ablation method, imaging, procedural data and fol-
low-up.
Risk of bias assessments for the included clinical
studies
The risk of bias within each individual study was eval-
uated by two reviewers (AAH, ZK) based on the nine-
star Newcastle–Ottawa Scale (NOS) using three pre-
defined domains namely: selection of participants,
comparability and ascertainment of outcomes of in-
terest. The NOS attributes a maximum of four points
for selection, two points for comparability, and three
points for outcome. Studies that received a score of
nine points were judged to be at low risk of bias; stud-
ies that scored seven or eight stars were considered at
medium risk; those that scored six or less were con-
sidered at high risk of bias (Appendix 4).
Data synthesis and analysis
The unpaired Student’s t-tests was used for demo-
graphic comparison of continuous variables between
groups. We used metaprop command to pool pro-
portions and we presented a weighted sub-group
and overall pooled estimates with inverse-variance
weights obtained from a random-effects model. Het-
erogeneity was quantified using the I2 statistic, classi-
fied as low (I2 ≤25%), moderate (I2 >25% and <75%),
or high (I2 ≥75%). Additionally, Q-statistic was used
to assess the presence of heterogeneity. PQ statis-
tic ≥0.05 was considered to indicate no significant
heterogeneity among the included studies. Study
characteristics including the location of the study,
duration of the study, age, male sex, left ventricular
function, the presence of VT storm at baseline and the
percentage of patients using amiodarone were pre-
specified as characteristics for assessment of hetero-
geneity and were evaluated using stratified analyses
and random-effects meta-regression if 10 or more
studies were included in the meta-analysis. Publi-
cation bias was evaluated through a funnel plot and
asymmetry was assessed using the Egger’s test. All
tests were two-tailed and p-values of 0.05 or less were
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Fig. 1 Flow chart of stud-
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(based on title/abstract)
(n=1244)






> not able to extract ischaemic origin VT: 16
> only in-hospital FU: 1
> FU < 1 year: 2
> analysis from study from before 2012: 1
> not English: 1
> abstract only: 4Studies included in qualitative synthesis
(n =38)
considered statistically significant. STATA release 14
(Stata Corp, College Station, Texas) was used for all
statistical analyses.
Results
Identification of relevant studies
The search strategy identified 2454 (1307 citations af-
ter excluding articles from before 2012), out of which
63 articles were found relevant following initial screen-
ing based on titles and abstracts. After full-text read-
ing, 25 articles were further excluded based on extrac-
tion of ischaemic VT data and the follow-up criteria.
A total of 38 articles were included that describe the
outcome of VT ablation [2, 4–40]. Of the 38 articles
five were image-guided [4–8]. Fig. 1 shows the selec-
tion process.
General characteristics of the included studies
Tab. 1 shows the key characteristics of the included
studies.
Baseline characteristics
A total number of 7748 patients with VT from is-
chaemic scar were included in this meta-analysis
(Tab. 2). Image-guided VT ablation had taken place in
224 patients. The majority of the non-image-guided
articles were by authors from the USA, whereas the
majority of the image-guided articles were by au-
thors from Europe. The average age was 65 years
and 89% was male. The average ejection fraction was
33%. Electrical storm was the reason for VT ablation
in 16–100% of the population in the 23 studies that
reported on it.
Substrate ablation was applied in 50% of the in-
cluded articles. Eighty percent of the image-guided
VT ablation articles primarily used a substrate ap-
proach. In 7 articles, targeted ablation was applied
and in one article [9] there was a direct comparison
between a targeted and a substrate approach. Three
articles, all non-image-guided, described ablation us-
ing remote magnetic navigation (49–100% of the pa-
tients). Seven articles, all non-image-guided, com-
mented on using assist devices in patients with non-
haemodynamically tolerable VTs. Fifty-five percent of
the patients in the image-guided ablation group and
94% in the conventional VT ablation group, were ICD
carriers (p=0.02) at baseline. Fifty-eight percent had
reported amiodarone use at the time of ablation.
No studies were judged at low bias of risk. Among
the observational studies, studies were judged to be at
median or high risk of bias. Among the randomised
controlled trials, studies were all judged at median
bias of risk.
Techniques used in image-guided VT ablation
Various types of image-guided ablation were reported.
One article reported on the use of imaging for plan-
ning the ablation strategy [5], 2 articles on imaging
integrated in the ablation procedure [7, 8], and 2 arti-
cles reported on doing both [4, 6]. One of the articles
that integrated imaging in the procedure used Auto-
matic Detection of Arrhythmic Substrate (ADAS) [8].
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Neijm [4] 2015 USA OS, Co, SC 8 17
Acosta [5] 2016 Spain OS, Co, SC 58 23
Yamashita [6] 2016 France OS, Co, SC 67 17
Yamashita [7] 2016 France OS, Co, SC 54 28
Andreu [8] 2017 Spain Os, Co, SC 37 20
B. Non-image-guided
Di Biase [9] 2012 Hungary, Italy, USA OS, Co, MC 92 25
Dinov [10] 2012 Germany OS, Co, SC 102 14
Arenal [11] 2013 Spain OS, Co, SC 59 38
Ghanem [12] 2013 Egypt OS, Co, SC 22 12
Tung [13] 2013 USA OS, Co, SC 69 12
Aryana [15] 2014 USA OS, Co, MC 36 19
Goya [16] 2014 Japan OS, Co, SC 51 41
Mork [17] 2014 Denmark OS, Co, SC 90 39
Saggu [18] 2014 India OS, Co, SC 5 46
Silberbauer [19] 2014 Italy OS, Co, SC 160 47
Tilz [20] 2014 Germany OS, Co, SC 12 40
Avila [2] 2015 Spain OS, Co, SC 46 32
Clemens [21] 2015 Czech Republic OS, Co, SC 31 46
De Riva [22] 2015 The Netherlands OS, Co, SC 91 23
Di Biase [23] 2015 China, Europa, USA RCT, MC 118 12
Izguierdo [24] 2015 Spain OS, Co, SC 50 13
Luther [25] 2015 UK OS, Co, SC 24 24
Pioretti [26] 2015 USA OS, Co, SC 87 54
Siontis [27] 2015 Europa, USA OS, Co, MC 1412 56
Tsiarchis [26] 2015 Italy OS, Co, SC 100 52
Tung [29] 2015 USA OS, Co, MC 1095 12
Yokokowa [14] 2015 USA OS, Co, SC 906 35
Acosta [30] 2016 Spain OS, Co, SC 44 46
Dinov [31] 2016 Germany OS, Co, SC 50 12
Frankel [32] 2016 Italy, Japan, USA OS, Co, MC 1095 12
Fukunaga [33] 2016 Japan OS, Co, SC 51 40
Ozcan [34] 2016 North America OS, Co, SC 44 28
Sapp [35] 2016 Europe, USA RCT, MC 132 28
Skoda [36] 2016 Czech Republic, Germany, USA OS, Co, MC 53 12
Jin [37] 2017 China, Denmark OS, Co, MC 54 17
Kuck [38] 2017 Germany RCT, MC 60 28
Kuroki [39] 2017 Japan OS, Co, MC 109 24
Tzou [40] 2017 USA, Japan OS, co, MC 1174 12
CO cohort, FU follow-up, MC multi-centre, ND no data, OS observational study, SC single-centre, RCT randomised controlled trial, VT ventricular tachycardia
Procedural difference in characteristics between
image-guided and non-image-guided VT ablation
Characteristics between the image-guided and non-
image-guided VT ablations were similar except for
a significant difference in percentage of patients who
had epicardial access; 37 in the image-guided ver-
sus 6 in the non-image-guided VT ablation (p< 0.01)
(Tab. 2).
Procedural data
Procedural duration was on average 4.5h in the im-
age-guided ablation versus 3.7h in the conventional
ablation procedure (p= 0.09). There was no signifi-
cant difference between radiofrequency time and flu-
oroscopy time in image-guided VT ablation versus
conventional ablation (Tab. 2).
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Table 2 Baseline characteristics of patients in included articles
Number of studies Image-guided Non-image-guided p-value
Age 38 64 66 0.07
EF 38 34 32 0.09
(%) (%)
Male 36 94 90 0.40
Infarct location Anterior 21 43 40 0.80
Inferoposterior 20 52 46 0.66
NYHA class III + IV 18 11 34 0.07
Electric storm 23 49 36 0.45
Diabetes mellitus 22 19 30 0.13
Hypertension 27 70 60 0.11
Amiodarone therapy 34 68 54 0.41
Prior VT ablation 23 32 15 0.14
Epicardial access 34 37 6 <0.01
ICD carrier 31 55 94 0.02
(min) (min)
Procedural duration 28 269 [250–] 220 [194–265] 0.09
Radiofrequency time 13 34 [32–] 38 [24–67] 0.93
Radiation exposure 24 54 [34–] 28 [15–38] 0.18
EF ejection fraction, NYHA New York Heart association, ICD implantable cardioverter defibrillator, VT ventricular tachycardia
Long-term outcome in VT ablation
Sixty-one percent (interquartile range [IQR] 54–67) of
the patients were free of VT recurrences during amean
follow-up duration of 35 months with an overall sur-
vival of 84% (IQR 80–88).
Outcome of image-guided VT ablation
The image-guided VT ablation reported a higher VT-
free survival of 82% [IQR 76–88] compared with the
non-image-guided VT ablations (59%, IQR 54–64,
p< 0.001) (Fig. 2). Overall survival was 94% (IQR
90–98) in the image-guided versus 82% (IQR 77–87)
in the conventional VT ablation (p< 0.001) (Fig. 3).
High between-study heterogeneity (random effects
model i2 93.56%, p<0.001) could not be explained by
any of the investigated between-study characteristics
(Supplementary file 1).
Discussion
The current meta-analysis shows an improved VT-free
and overall survival in patients with ischaemic VT by
using image-guided VT ablation compared with con-
ventional VT ablation. This is the first study that
demonstrates true large-scale benefit. Visualising my-
ocardial scar and integrating imaging in the procedure
facilitates VT ablation by focussing on the area of in-
terest and providing more accurate substrate charac-
terisation.
Imaging-derived scar versus electroanatomical
mapping
Generally, there is a good correlation between bipo-
lar voltage mapping and computed tomography and
MRI-derived scar [6, 41]. Increased transmurality of
the scar on MRI correlated well with reduced bipolar
low voltage on the endocardium [42], suggesting the
presence of low voltage in the epicardium.
However, voltage mapping may fail to accurately
delineate the extent of diseased myocardium because
of limitations such as catheter contact issues, reduced
sensitivity to far-field signal of the mid-myocardium
[43], and the interposition of epicardial fat [44]. Epi-
cardial fat may lead to false-negative low voltage on
epicardial voltage mapping, computed tomography
accurately visualises epicardial fat and differentiates
it from scar [44]. Scar is a 3-dimensional structure
and consequently a voltage map has a limited spa-
tial resolution. Moreover, a bipolar voltage map may
show absence of low voltage in the presence of an in-
tramural scar and, therefore, may be missed. It is po-
tentially unmasked with unipolar recordings, but may
be best visualised with MRI. In the presence of an in-
tramural scar, VT recurrences occur more frequently
[4]. Recognising the presence of intramural scar, high-
output endocardial ablation, bipolar ablation or a ra-
diofrequency needle ablation catheter may reach the
mid-myocardium and successfully ablate the VT cir-
cuit [45].
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Fig. 2 Forest plot of VT-free survival—image-guided versus non-image-guided. (CI confidence interval, ES effect size, VT ven-
tricular tachycardia)
Limitations of MRI
The use of cardiac MRI in VT ablation has certain lim-
itations. Currently there is no consensus on, nor stan-
dardisation of, image postprocessing [46]. Another
limitation is the presence of artefacts that derive from
ICDs, most commonly affecting the basal left anterior
free wall. The presence of devices not only limits the
interpretations of scar tissue on MRI, but also affects
the reliability of contrast-enhanced imaging due to
provoked hyper-intense off-resonance artefacts mim-
icking scar tissue [47]. The wideband inversion re-
covery late gadolinium enhancement (LGE) MRI tech-
nique can potentially overcome this type of artefact
[48].
Furthermore, errors can arise with image integra-
tion as well. Geometry can change due to respira-
tory and cardiac motion, and conformational changes
can occur between the time of MRI and the abla-
tion procedure due to, for example, differences in vol-
ume or rhythm [47]. Partial-volume effects on the
standard thickness short-axis slices, for example, can
lead to overestimation of border zone areas [49]. In
EP procedures this is a known phenomenon. During
electroanatomical mapping (EAM), the mean maxi-
mum amplitude of cardiac and respiratory motion
was 10.2± 2.7mm and 8.8± 2.3mm respectively [50].
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Fig. 3 Forest plot survival—image-guided versus non-image-guided. (CI confidence interval, ES effect size, VT ventricular
tachycardia)
This may be especially critical in the identification of
conduction channels.
Using real-time MRI minimalises conformational
changes. Non-contrast-enhanced T1-weighted imag-
ing with long T1 decay times is promising as it was
shown to be an effective method for visualising necro-
sis within radiofrequency ablation lesions. Enhance-
ment is more specific and stationary than that from
contrast LGEMRI. Scar tissue appears dark in the non-
contrast-enhanced images, allowing to differentiate
between acute radiofrequency ablations and chronic
scar [51]. Cardiac motion correction by cardiac trig-
gering improves precision in myocardial T1 mapping
[52].
Image-guided ablation strategy
Epicardial ablation in ischaemic VT is usually re-
stricted to patients with previous failed endocardial
ablation attempts. Yet, there is a relation between
complete VT substrate elimination and better ab-
lation outcomes [11]. The importance of complete
substrate ablation is in the assumption that substrate
not related to clinical or inducible VT can activate
and become a VT isthmus during follow-up. Epicar-
dial border zone channels in post-MI transmural scar
are seen in 63% [3].
However, if epicardial ablation is used as a first-
line ablation a significant proportion of patients un-
dergoing epicardial mapping do not exhibit an epi-
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cardial arrhythmogenic substrate [9]. Which is why
tools are needed to avoid unnecessary pericardial ex-
plorations. Acosta et al. showed that endocardial ab-
lation in patients with a transmural scar on MRI re-
sulted in a significantly lower recurrence-free survival
compared with complete substrate ablation [5].
Scar characterisation
A large area of scar heterogeneity predicts recurrence
of VT after VT ablation [4]. Furthermore, successful
ablation appears to be in localised areas of hetero-
geneity, and incomplete ablation in these areas pre-
dicts VT recurrence in animal models [53]. The de-
layed components of the conducting channel electro-
grams reflect the presence and activation of viable fi-
bres embedded in fibrosis [54]. Border zone channels
display a 3D structure within the myocardial wall that
can be depicted by contrast-enhanced MRI [3]. Criti-
cal sites of ischaemic VT are confined to areas of high
signal intensity. Channels on MRI correlate with areas
of survival myocardial tissue which help to better lo-
cate the target ablation sites and find critical channels
in the areas of normal voltage [8, 55]. Identification
of conductive channels on EAM aided by pixel inten-
sity maps improved when based on 3D imaging with
1.4× 1.4× 1.4-mm resolution compared with conven-
tional 2-dimensional clinical imaging with 5-mm slice
thickness [3]. Identification of conduction channels
in the electroanatomical map can be improved when
using a cut-off value of 60% of the maximum pixel
signal intensity, both for core and border zone. Using
computed tomography, thicker ridges within areas of
pronounced wall thinning in the scar, seen as rela-
tively preserved wall thickness, are recognised as the
arrhythmogenic substrate of scar-related VT [56].
Critical VT isthmus sites in patient with priorMI are
located in close proximity to the area on MRI where
transition between >75% transmural scar and the core
border zone occurs [57]. Critical isthmus sites around
the core border zone transition suggest that the signal
intensity threshold of a maximal 50% may indicate
a critical mix between fibrosis and viable myocytes
that allow for slow conduction and thereby, re-entrant
VT. Currently, however, 3D imaging and postprocess-
ing methods may still be limited at detecting fraction-
ated and late potential regions within EAM dense scar
[3].
Image integration
Real-time integration of VT substrate helps focusing
on diseased versus healthy areas of the myocardium.
Yamashita et al. showed that despite a similar number
of mapping points a higher number of local abnormal
ventricular activities (LAVA) sites could be identified in
patients who had ablation guided by imaging data [6].
More efficient mapping focuses towards the critical
areas when guided by imaging data and leads to better
long-term freedom of VT [7, 8].
Clinical implications
Imaging guidance for VT ablation is not mentioned
in the current ventricular arrhythmia guidelines [58].
The current meta-analysis suggests benefit in VT-free
and overall survival by the use of image guidance in
VT ablation for patients with ischaemic heart disease.
Larger-scale randomised studies are needed to con-
firm our results. Furthermore, we are in need of stud-
ies that teach us about the cost-effectiveness of image-
guided VT ablation.
Limitations
Despite the fact that this is the largest image-guided
VT ablation cohort so far, there are several limitations
to note, some inherent to performing a meta-anal-
ysis. First, some data on patient level was unavail-
able in the included studies, which precluded a de-
tailed evaluation to identify the impact of particular
baseline demographic characteristics (i.e., number of
ICD shocks before the ablation), type of imaging used
(computed tomography or contrast-enhanced cardiac
magnetic resonance) and procedural factors (use of
magnetic navigation or contact force) on the outcome
of freedom of VT. Additionally, we were not able to ex-
tract data on the correlation between ablation strat-
egy (substrate versus targeted arrhythmia approach)
and long-term outcomes in all of the eligible studies.
There were significantly less patients with an ICD at
the time of inclusion in the image-guided group even
though ejection fraction was similar. A possible expla-
nation for the low percentage of patients who had an
ICD implanted at baseline is selection bias, patients
without an implanted ICD during their presentation
with VT were possibly more prone to undergoMRI be-
fore ablation. ICD patients benefit from a continuous
monitoring system, it could influence the detection
of VT during follow-up. We cannot exclude that an
ICD was implanted during follow-up. Higher VT-free
and overall survival has been seen in patients treated
with a substrate approach including epicardial abla-
tion compared with a limited ablation [9]. Patients
with image-guided VT ablation more often had a sub-
strate approach and had a higher percentage of epi-
cardial access, which, in itself, could be an explana-
tion for the lower number of recurrences in this group.
Yet, determining an ablation strategy is one of the po-
tential benefits from image-guided VT ablations [5].
There was minimal publication bias as indicated by
conventional funnel plots and Egger test (Supplemen-
tary file 2), however, these approaches are limited by
their qualitative nature. The majority of the included
studies were observational in nature, with higher risk
of selection bias. Randomised controlled trials are
needed to convince the effectiveness of imaging data
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for VT ablation procedures. Limited scanning capac-
ity and additional costs could hinder implementation.
Currently, we cannot be confident that our results
are merely a reflection of the contribution of image-
guided ablation.
Conclusion
Image-guided VT ablation was found to be associ-
ated with a significant benefit in VT-free and overall
survival as compared to conventional VT ablation.
Visualising myocardial scar may facilitate substrate-
guided ablation procedures, pre-procedurally and by
integrating imaging in the procedure, and conse-
quently may improve long-term outcome.
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34. Özcan F, Topaloğlu S, Çay S, et al. Catheter ablation of
drug refractory electrical storm in patients with ischemic
cardiomyopathy: a single center experience. Anatol J
Cardiol. 2016;16(3):159–64.
35. Sapp JL,Wells GA, ParkashR, et al. Ventricular tachycardia
ablationversusescalationofantiarrhythmicdrugs.NEngl J
Med. 2016;375(2):111–21.
36. SkodaJ,AryaA,GarciaF,etal. Catheterablationof ischemic
ventricular tachycardia with remote magnetic navigation:
STOP-VT multicenter trial. J Cardiovasc Electrophysiol.
2016;27(Suppl1):S29–S37.
37. JinQ, JacobsenPK,PehrsonS,ChenX.Predictionandprog-
nosis of ventricular tachycardia recurrence after catheter
ablation with remote magnetic navigation for electrical
storm in patients with ischemic cardiomyopathy. Clin
Cardiol. 2017;40:1083–9.
38. KuckKH,TilzRR,DenekeT, et al. Impactof substratemod-
ification by catheter ablation on implantable cardioverter-
defibrillator interventions in patients with unstable ven-
tricular arrhythmias and coronary artery disease results
from the multicenter randomized controlled SMS (sub-
strate modification study). Circ Arrhythm Electrophysiol.
2017;10:e4422.
39. Kuroki K, Nogami A, Yoshida K, et al. Efficacy of intensive
radiofrequency energy delivery to the localized dense scar
area in post-infarction ventricular tachycardia ablation.
A comparative study with standard strategy targeting the
infarctedborderzone. CircJ.2017;81:1603–10.
40. TzouWS, Tung R, Frankel DS, et al. Outcomes after repeat
ablation of ventricular tachycardia in structural heart dis-
ease: ananalysis fromthe InternationalVTAblationCenter
CollaborativeGroup.HeartRhythm. 2017;14(7):991–7.
41. Perez-David E, Arenal A, Rubio-Guivernau JL, et al. Non-
invasive identification of ventricular tachycardia-related
conducting channels using contrast-enhanced magnetic
resonance imaging in patients with chronic myocardial
infarction: comparison of signal intensity scar mapping
and endocardial voltage mapping. J Am Coll Cardiol.
2011;57:184–94.
42. Dickfeld T, Tian J, Ahmad G, et al. MRI-guided ven-
tricular tachycardia ablation: integration of late gadolin-
ium-enhanced 3D scar in patients with implantable car-




resonance imaging and electroanatomical voltage map-
ping to assess post-infarct scar characteristics in patients
with ventricular tachycardias: real-time image integration
andreversedregistration. EurHeartJ.2011;32:104–14.
44. Desjardins B, Morady F, Bogen F. Effect of epicardial fat
on electroanatomical mapping and epicardial catheter
ablation. JAmCollCardiol. 2010;56:1320–7.
45. Sapp JL,BeecklerC,PikeR, etal. Initial human feasibilityof
infusionneedle catheter ablation for refractory ventricular
tachycardia. Circulation. 2013;128(21):2289–95.
46. CarapellaV,PuchtaH,LukaschukE, etal. Standardized im-
agepost-processing of cardiovascularmagnetic resonance
T1-mappingreducesvariabilityandimprovesaccuracyand
consistency in myocardial tissue characterization. Int J
Cardiol. 2020;298:128–34.
47. Mukherjee RK, Whitaker J, Williams SE, Razavi R,
O’Neill MD. Magnetic resonance imaging guidance for
the optimization of ventricular tachycardia ablation.
Europace. 2018;20:1721–32.
48. Runge M, Ibrahim EH, Bogun F, et al. Metal artifact re-
duction incardiovascularMRI for accuratemyocardial scar
assessment inpatientswith cardiac implantable electronic
devices. AJRAmJRoentgenol. 2019;213(3):555–61.
49. Mukherjee RK, Whitaker J, Williams SE, Razavi R,
O’Neill MD. Magnetic resonance imaging guidance for
the optimization of ventricular tachycardia ablation.
Europace. 2018;20:1721–32.
50. Roujol S, Anter E, Josephson ME, Nezafat R. Character-
isation of respiratory and cardiac motion from electro-
anatomicalmappingdata for improvedfusionofMRI to left
ventricularelectrograms. PlosOne. 2013;8:e78852.
51. Guttman MA, Tao S, Fink S, Kolandaivelu A, Halperin HR,
Herzka DA. Non-contrast-enhanced T1-weighted MRI of
myocardial radiofrequency ablation lesions. Magn Reson
Med. 2018;79(2):879–89.
52. Becker KM, Blaszczyk E, Funk S, et al. Fast myocardial T1
mapping using cardiac motion correction. Magn Reson
Med. 2020;83:438–51.
53. EstnerHL,ZvimanMM,HerzkaD,etal. Thecritical isthmus
sites of ischemic ventricular tachycardia are in zones of
582 Pre-procedural image-guided versus non-image-guided ventricular tachycardia ablation—a review
Original Article
tissue heterogeneity, visualized my magnetic resonance
imaging.HeartRhythm. 2011;8:1942–9.
54. Gardner PI, Ursell PC, Fenoglio JJ Jr, Wit AL. Electrophys-
iologic and anatomic basis for fractionated electrograms
recorded from healed myocardial infarcts. Circulation.
1985;72:596–611.
55. AndreuD,BerruezoA,Ortiz-PérezJT,etal. Integrationof3D
electroanatomicmaps andmagnetic resonance scar char-
acterization into the navigation system to guide ventric-
ular tachycardia ablation. Circ Arrhythm Electrophysiol.
2011;4:674–83.
56. Ghannam M, Cochet H, Jais P, et al. Correlation between
computer tomography-derived scar topography and criti-
cal ablation sites in postinfarction ventricular tachycardia.
JCardiovascElectrophysiol. 2018;29(3):438–45.
57. Piers SRD, Tao Q, de Riva Silva M, et al. CMR-based
identification of critical isthmus sites of ischemic and
nonischemic ventricular tachycardia. JACC Cardiovasc
Imaging. 2014;7:774–84.
58. Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/
APHRSexpertconsensusonventriculararrhythmias.Heart
Rhythm. 2014;11(10):e166–96.
Pre-procedural image-guided versus non-image-guided ventricular tachycardia ablation—a review 583
